Hide

FocusBar

Subscribe to Premium Member
Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,733Revenue $M749Net Margin (%)16.3Z-Score17.5
Enterprise Value $M3,476EPS $3.2Operating Margin %22.1F-Score5
P/E(ttm))28.2Cash Flow Per Share $3.0Pre-tax Margin (%)22.1Higher ROA y-yY
Price/Book3.410-y EBITDA Growth Rate %21.2Quick Ratio3.5Cash flow > EarningsN
Price/Sales4.95-y EBITDA Growth Rate %2.6Current Ratio5.8Lower Leverage y-yN
Price/Cash Flow23.3y-y EBITDA Growth Rate %22.8ROA % (ttm)9.7Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)11.2Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M40.5ROI % (ttm)12.2Gross Margin Increase y-yN

Gurus Latest Trades with DRQ

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Number of guru portfolios checked: 51.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DRQMario Gabelli 2011-03-31 Reduce$71.56 - $81.36
($76.63)
$ 91.1119%Reduce -21.18%11,350
DRQMario Gabelli 2010-09-30 Buy $44.43 - $63.13
($53.55)
$ 91.1170%New holding, 16100 sh.16,100
DRQJohn Keeley 2009-12-31 Add0.23%$48.31 - $58.79
($53.97)
$ 91.1169%Add 151.55%446,250
DRQJohn Keeley 2009-09-30 Buy 0.13%$35.13 - $49.77
($42.35)
$ 91.11115%New holding, 177400 sh.177,400
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DRQ is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
DRQ John Keeley 2013-03-31463,1411.140.79-1.47%
DRQ Mario Gabelli 2013-03-316,7000.020-2.9%
Premium Most recent portfolio changes are included for Premium Members only!


DRQ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Robertson L H DickDirector 2013-05-13Sell187$90.9-0.51view
SHUKIS A PDirector 2013-05-13Sell187$90.87-0.47view
Gariepy James A.SR V.P. and COO 2013-03-26Sell10,000$87.13.83view
BROOKS JERRY MVP - Finance and CFO 2013-03-26Sell10,000$87.393.49view
DeBerry Blake T.President and CEO 2013-03-26Sell10,000$87.013.94view
BROOKS JERRY MVP - Finance and CFO 2012-12-10Sell753$70.3528.56view
Gariepy James A.SR V.P. and COO 2012-12-10Sell2,259$70.3528.56view
DeBerry Blake T.President and CEO 2012-12-10Sell2,259$70.3528.56view
Webster James C.VP - General Counsel and Sec 2012-12-10Sell753$70.3528.56view
REIMERT LARRY ECo-Chairman of the Board 2010-12-28Sell21,456$77.4416.79view

Press Releases about DRQ:

Quarterly/Annual Reports about DRQ:

News about DRQ:

Articles On GuruFocus.com
James Montier’s Short Screen Aug 08 2012 
DrilQuip Inc. Reports Operating Results (10-K) Feb 28 2011 
DrilQuip Inc. (DRQ) Co-Chairman of the Board Larry E Reimert sells 21,456 Shares Dec 29 2010 
DrilQuip Inc. (DRQ) Co-Chairman of the Board Larry E Reimert sells 42,632 Shares Dec 27 2010 
DrilQuip Inc. (DRQ) Co-Chairman of the Board Larry E Reimert sells 64,266 Shares Dec 20 2010 
DrilQuip Inc. Reports Operating Results (10-Q) Nov 04 2010 
Ken Fisher Q3: Buys Wells Fargo, LQD, TMK, Sells UNH, GIS, SCHW Nov 01 2010 
DrilQuip Inc. Reports Operating Results (10-Q) Aug 06 2010 
John Keeley Buys W.R. Grace & Co., American Water Works Company Inc, Bemis Company Inc., Encana Corp Feb 19 2010 
DrilQuip Inc. (DRQ) Co-Chairman of the Board, 10% Owner J Mike Walker sells 184,614 Shares Dec 16 2009 

Add Notes, Comments or Ask Questions

Comments

No comment yet
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial
FEEDBACK